A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome

NCT03162783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: ADX-102 Ophthalmic Solution (0.5%)
DRUG: ADX-102 Ophthalmic Solution (0.1%)
DRUG: ADX-102 Ophthalmic Lipid Solution (0.5%)

Sponsor

Aldeyra Therapeutics, Inc.